Patent · US Active

Fatty acid guanidine and salicylate guanidine derivatives and their uses

US9150504B2 · kind B2 · utility

2Cited by

2References

18Claims

0Family size

Assignee

Catabasis Pharmaceuticals, Inc. · US

Inventors

Jill C. Milne · Brookline, US
Michael R. Jirousek · Cambridge, US
Jean E. Bemis · Arlington, US
Chi B. Vu · Cambridge, US
Amal Ting · Newton, US

Key dates

Filing date	Apr 27, 2012
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Apr 30, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C279/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to fatty acid guanidine or salicylate guanidine derivatives; compositions comprising an effective amount of a fatty acid guanidine or salicylate guanidine derivative; and methods for treating or preventing a metabolic disease comprising the administration of an effective amount of a fatty acid guanidine or salicylate guanidine derivative.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.